Seres Therapeutics Inc —— 资产负债表 (NASDAQ:MCRB) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 342.94 M354.86 M348.78 M358.6 M139.81 M138.19 M 负债总额 168.19 M223.35 M338 M403.46 M126.03 M93.97 M 权益总额 174.75 M131.51 M10.78 M-44.86 M13.78 M44.22 M 负债及股东权益总额 342.94 M354.86 M348.78 M358.6 M139.81 M138.19 M 总债务 25.09 M24.64 M51.05 M101.54 M0— 净债务 -228.52 M-266.06 M-130.29 M-26.42 M-30.79 M—

新闻

Seres Therapeutics将2026年年度股东大会定于6月9日举行

Seres Therapeutics schedules 2026 annual meeting for June 9

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres股价下跌，因暂停二期研究并裁员30%

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics发布VOWST机制新见解

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences任命David A. Berry为董事

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres to present new data on SER-155 bloodstream infection study